Sign in
4

Changes in Ownership

Calidi Biotherapeutics, Inc. Filed Acc 0001493152-26-039288

Options or other derivatives

  • Director acquired 5,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Schoeneck James A Director 2026-08-17 Grant or award · Non-Qualified Stock Options (right to buy) +5,000 5,000 D
Loading xslF345X06/ownership.xml…